ChAd-triCoV/Mac

BIOLOGICAL2 trials

Sponsors

McMaster University

Conditions

COVID-19COVID-19 InfectionSARS-CoV2 Infection

Phase 1

Phase 1 Trial of ChAd68 and Ad5 Adenovirus COVID-19 Vaccines Delivered by Aerosol

CompletedNCT05094609

McMaster UniversityCOVID-19, SARS-CoV2 Infection

Start: 2022-01-03End: 2025-01-31Updated: 2025-07-17

Phase 2

A Trial of a Next Generation COVID-19 Vaccine Delivered by Inhaled Aerosol

RecruitingNCT06381739

McMaster UniversityCOVID-19 Infection

Start: 2025-03-25End: 2027-01-01Target: 350Updated: 2026-01-26

Related Papers

Induction of lung mucosal immunity by a next-generation inhaled aerosol COVID-19 vaccine: an open-label, multi-arm phase 1 clinical trial

Nature Communications2025-07-028 citations